Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

Disclosure of Large Shareholding - Nykode Therapeutics ASA

Nykode Therapeutics
Please find the attached notifications as of 10 October 2025 submitted on behalf
of The Capital Group Companies, Inc. ("CGC") and SMALLCAP World Fund, Inc.
("SCWF") due to the purchase of shares.

Please note that the notification submitted on behalf of CGC as of 10 October
2025 included SCWF's holdings.

SCWF is a mutual fund registered in the United States under the Investment
Company Act of 1940. SCWF is the legal owner of the 16,387,015 shares held
(5.018% of total voting rights and 5.018% of total share capital) as of 10
October 2025. SCWF has granted proxy voting authority to Capital Research and
Management Company ("CRMC"), its investment adviser. As noted in the letter, CGC
is the parent company of CRMC.

Please see attachments on www.newsweb.no
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.